相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Unintended Consequences Following the 2014 American Academy of Pediatrics Policy Change for Palivizumab Prophylaxis among Infants Born at Less than 29 Weeks' Gestation
Mitchell Goldstein et al.
AMERICAN JOURNAL OF PERINATOLOGY (2021)
Medication utilization in children born preterm in the first two years of life
Jonathan C. Levin et al.
JOURNAL OF PERINATOLOGY (2021)
SENTINEL1: Two-Season Study of Respiratory Syncytial Virus Hospitalizations among US Infants Born at 29 to 35 Weeks' Gestational Age Not Receiving Immunoprophylaxis
Evan J. Anderson et al.
AMERICAN JOURNAL OF PERINATOLOGY (2020)
Estimates of healthcare spending for preterm and low-birthweight infants in a commercially insured population: 2008-2016
Andrew L. Beam et al.
JOURNAL OF PERINATOLOGY (2020)
Cost-effectiveness of Palivizumab for Respiratory Syncytial Virus: A Systematic Review
Stephen Mac et al.
PEDIATRICS (2019)
RESPIRATORY VIRUS EPIDEMIOLOGY AMONG US INFANTS WITH SEVERE BRONCHIOLITIS: ANALYSIS OF 2 MULTICENTER, MULTIYEAR COHORT STUDIES
Kohei Hasegawa et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2019)
Respiratory Syncytial Virus Hospitalizations among US Preterm Infants Compared with Term Infants Before and After the 2014 American Academy of Pediatrics Guidance on Immunoprophylaxis: 2012-2016
Mitchell Goldstein et al.
AMERICAN JOURNAL OF PERINATOLOGY (2018)
Respiratory Syncytial Virus Seasonality - United States, 2014-2017
Erica Billig Rose et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2018)
Population-based trends and underlying risk factors for infant respiratory syncytial virus and bronchiolitis hospitalizations
Mihoko Bennett et al.
PLOS ONE (2018)
Assessing Variation in the Cost of Palivizumab for Respiratory Syncytial Virus Prevention in Preterm Infants
Ahva Shahabi et al.
PHARMACOECONOMICS-OPEN (2018)
The 2014-2015 National Impact of the 2014 American Academy of Pediatrics Guidance for Respiratory Syncytial Virus Immunoprophylaxis on Preterm Infants Born in the United States
Amanda M. Kong et al.
AMERICAN JOURNAL OF PERINATOLOGY (2018)
SENTINEL1: An Observational Study of Respiratory Syncytial Virus Hospitalizations among US Infants Born at 29 to 35 Weeks' Gestational Age Not Receiving Immunoprophylaxis
Evan J. Anderson et al.
AMERICAN JOURNAL OF PERINATOLOGY (2017)
Respiratory syncytial virus hospitalization and mortality: Systematic review and meta-analysis
Renato T. Stein et al.
PEDIATRIC PULMONOLOGY (2017)
Impact of the Updated Guidance for Palivizumab Prophylaxis against Respiratory Syncytial Virus Infection: A Single Center Experience
Bavani Rajah et al.
JOURNAL OF PEDIATRICS (2017)
Evaluation of the Financial and Health Burden of Infants at Risk for Respiratory Syncytial Virus
Stephanie McCallum Blake et al.
ADVANCES IN NEONATAL CARE (2017)
Mortality due to Respiratory Syncytial Virus Burden and Risk Factors
Sarah Geoghegan et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
Community-Acquired Pneumonia Requiring Hospitalization among US Children
Seema Jain et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Efficacy and Optimization of Palivizumab Injection Regimens Against Respiratory Syncytial Virus Infection
Alexander Gutfraind et al.
JAMA PEDIATRICS (2015)
The Underrecognized Burden of Respiratory Syncytial Virus Among Infants Presenting to US Emergency Departments
Doris Makari et al.
CLINICAL PEDIATRICS (2015)
Respiratory Syncytial Virus-Associated Mortality in Hospitalized Infants and Young Children
Carrie L. Byington et al.
PEDIATRICS (2015)
Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection
Michael T. Brady et al.
PEDIATRICS (2014)
Trends in Bronchiolitis Hospitalizations in the United States, 2000-2009
Kohei Hasegawa et al.
PEDIATRICS (2013)
Appropriateness of Age Thresholds for Respiratory Syncytial Virus Immunoprophylaxis in Moderate-Preterm Infants A Cohort Study
Almut G. Winterstein et al.
JAMA PEDIATRICS (2013)
Respiratory Syncytial Virus-associated Hospitalizations Among Infants and Young Children in the United States, 1997-2006
Lauren J. Stockman et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2012)
The Burden of Respiratory Syncytial Virus Infection in Young Children
Caroline Breese Hall et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Policy Statement-Modified Recommendations for Use of Palivizumab for Prevention of Respiratory Syncytial Virus Infections
Joseph A. Bocchini et al.
PEDIATRICS (2009)
Rates of hospitalization for respiratory syncytial virus infection among children in Medicaid
TG Boyce et al.
JOURNAL OF PEDIATRICS (2000)
分享论文
